The Mediation Effect of Peripheral Biomarkers of Calcium Metabolism and Chronotypes in Bipolar Disorder Psychopathology.
bipolar disorder
calcium metabolism
chronobiology
chronotype
circadian rhythm
parathormon
sleep
vitamin D
Journal
Metabolites
ISSN: 2218-1989
Titre abrégé: Metabolites
Pays: Switzerland
ID NLM: 101578790
Informations de publication
Date de publication:
02 Sep 2022
02 Sep 2022
Historique:
received:
08
08
2022
revised:
31
08
2022
accepted:
01
09
2022
entrez:
23
9
2022
pubmed:
24
9
2022
medline:
24
9
2022
Statut:
epublish
Résumé
Calcium (Ca++) metabolism may be impaired in several psychiatric diseases. We hypothesize that calcium imbalance might also correlate with a specific chronotype and could be recognized as a marker of illness severity in bipolar disorder (BD). We aimed to (1) identify the association between calcium imbalance and a specific chronotype in a cohort of BD patients, and (2) test the mediation role of high parathyroid hormone (PTH) levels towards a specific chronotype and illness severity in BD patients. Patients’ socio-demographic and clinical characteristics were collected with an ad-hoc schedule. We administered the Hamilton Depression Rating Scale (HAM-D), the Hamilton Rating Scale for Anxiety (HAM-A), the Young Mania Rating Scale (YMRS), and the Morningness Eveningness Questionnaire (MEQ). 100 patients affected by BD were recruited. The Kruskal-Wallis test showed a significant difference between the three MEQ groups in PTH levels (p < 0.001) and vitamin D levels (p = 0.048) but not in Ca++ levels (p = 0.426). Dwass-Steel-Critchlow-Fligner Pairwise analyses performed concerning three MEQ groups revealed significantly higher scores on PTH levels in MEQ-E subjects compared to MEQ-M and MEQ-I (in both cases, p < 0.001). No differences emerged between calcium levels among the three chronotypes. The mediation analysis has shown that elevated PTH levels are directly influenced by more severe HAM-A, HAM-D, and YMRS scores. MEQ-E could be a marker related to BD and predispose to various factors influencing mood symptoms. The combination of vitamin D therapy in MEQ-E may help to improve prognosis in this subtype of patients affected by BD.
Identifiants
pubmed: 36144231
pii: metabo12090827
doi: 10.3390/metabo12090827
pmc: PMC9505716
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Eur J Neurosci. 2020 Jan;51(1):551-566
pubmed: 30269362
J Chem Neuroanat. 2005 Jan;29(1):21-30
pubmed: 15589699
Int J Mol Sci. 2020 Mar 03;21(5):
pubmed: 32138257
Chronobiol Int. 2015;32(10):1343-51
pubmed: 26540575
Proc Natl Acad Sci U S A. 2005 Aug 23;102(34):12071-6
pubmed: 16093318
J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62
pubmed: 14399272
Biomolecules. 2021 Mar 24;11(4):
pubmed: 33804974
Front Neurosci. 2021 May 13;15:670879
pubmed: 34054418
Cold Spring Harb Perspect Biol. 2017 Jan 3;9(1):
pubmed: 28049647
Cureus. 2018 Jul 10;10(7):e2960
pubmed: 30214848
Med Hypotheses. 2007;69(6):1316-9
pubmed: 17499448
Front Neurosci. 2019 Apr 12;13:348
pubmed: 31031586
J Clin Endocrinol Metab. 1997 Jan;82(1):281-6
pubmed: 8989274
Science. 2010 Oct 15;330(6002):379-85
pubmed: 20947768
Braz J Psychiatry. 2022 Jan-Feb;44(1):35-40
pubmed: 35170673
PLoS Genet. 2013;9(12):e1003975
pubmed: 24348262
Aust N Z J Psychiatry. 2013 Apr;47(4):321-32
pubmed: 23411094
Indian J Psychol Med. 2020 Jan 06;42(1):11-21
pubmed: 31997861
Methodist Debakey Cardiovasc J. 2017 Apr-Jun;13(2):49-54
pubmed: 28740581
Metabolites. 2022 Jan 25;12(2):
pubmed: 35208186
Annu Rev Nutr. 2014;34:117-41
pubmed: 25033060
Am J Clin Nutr. 2011 Oct;94(4):1104-12
pubmed: 21865327
J Nutr Sci. 2018 Aug 23;7:e23
pubmed: 30197783
Int Arch Med. 2010 Nov 11;3:29
pubmed: 21067618
Exp Clin Cardiol. 2011 Winter;16(4):109-15
pubmed: 22131852
Psychol Health Med. 2015;20(3):345-52
pubmed: 25162477
J Clin Invest. 2017 Apr 3;127(4):1146-1154
pubmed: 28240603
Chronobiol Int. 2015 Feb;32(1):37-42
pubmed: 25153134
Free Radic Biol Med. 2018 May 1;119:45-55
pubmed: 29398284
Biol Res. 2004;37(1):11-28
pubmed: 15174302
Kidney Int. 2020 Dec;98(6):1461-1475
pubmed: 32721445
Science. 2010 Oct 15;330(6002):329-30
pubmed: 20947752
Br J Psychiatry. 1978 Nov;133:429-35
pubmed: 728692
Nutrients. 2021 Nov 24;13(12):
pubmed: 34959758
Brain Sci. 2020 Jul 01;10(7):
pubmed: 32630307
Front Physiol. 2019 Jun 25;10:682
pubmed: 31293431
Chronobiol Int. 2019 Feb;36(2):181-187
pubmed: 30299170
Int J Mol Sci. 2019 Nov 19;20(22):
pubmed: 31752330
Neuron. 2018 May 2;98(3):466-481
pubmed: 29723500
Nutrients. 2014 Oct 28;6(11):4720-30
pubmed: 25353666
PLoS One. 2011 Mar 03;6(3):e17553
pubmed: 21408608
Chronobiol Int. 2017;34(8):1105-1113
pubmed: 28708003
Sleep Med Rev. 2017 Aug;34:46-58
pubmed: 27524206
Handb Exp Pharmacol. 2013;(217):67-103
pubmed: 23604476
Signal Transduct Target Ther. 2022 Feb 8;7(1):41
pubmed: 35136018
Front Mol Neurosci. 2021 May 11;14:666673
pubmed: 34045944
Eur J Endocrinol. 2002 May;146(5):635-42
pubmed: 11980618
Genes Nutr. 2018 Jul 11;13:19
pubmed: 30008960
Chronobiol Int. 2015 Apr;32(3):405-15
pubmed: 25469597
J Affect Disord. 1988 Jan-Feb;14(1):61-8
pubmed: 2963053
Braz J Psychiatry. 2020 Jan-Feb;42(1):68-71
pubmed: 31269097
World Psychiatry. 2017 Oct;16(3):236-244
pubmed: 28941093
Bipolar Disord. 2018 Sep;20(6):515-522
pubmed: 29441659
Nat Commun. 2019 Oct 16;10(1):4693
pubmed: 31619668
J Physiol. 1999 Sep 1;519 Pt 2:451-66
pubmed: 10457062
Biology (Basel). 2019 May 11;8(2):
pubmed: 31083546
J Affect Disord. 2020 Apr 1;266:556-562
pubmed: 32056926
Virus Res. 2021 Jan 15;292:198235
pubmed: 33232783
Psychiatry Res. 2011 Dec 30;190(2-3):221-5
pubmed: 21784535
Cochrane Database Syst Rev. 2018 May 14;5:CD010753
pubmed: 29761479
PLoS Comput Biol. 2007 Apr 13;3(4):e68
pubmed: 17432930
Science. 2016 Nov 25;354(6315):1008-1015
pubmed: 27885007